UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate

Current pharmaceutical design, 2007-07, Vol.13 (20), p.2057-2073

2007

Volltextzugriff (PDF)

Heparin-derived heparan sulfate mimics to modulate heparan sulfate-protein interaction in inflammation and cancer

Matrix biology, 2010-07, Vol.29 (6), p.442-452

2010

Volltextzugriff (PDF)

SST0001, a Chemically Modified Heparin, Inhibits Myeloma Growth and Angiogenesis via Disruption of the Heparanase/Syndecan-1 Axis

Clinical cancer research, 2011-03, Vol.17 (6), p.1382-1393

2011

Volltextzugriff (PDF)

Modulation of the Heparanase-inhibiting Activity of Heparin through Selective Desulfation, Graded N-Acetylation, and Glycol Splitting

The Journal of biological chemistry, 2005-04, Vol.280 (13), p.12103-12113

2005

Volltextzugriff (PDF)

Orthogonal analytical approaches to detect potential contaminants in heparin

Proceedings of the National Academy of Sciences - PNAS, 2009-10, Vol.106 (40), p.16956-16961

2009

Volltextzugriff (PDF)

Structure and biological interactions of heparin and heparan sulfate

Advances in Carbohydrate Chemistry and Biochemistry, 2001-01, Vol.57, p.159-206

2001

Volltextzugriff (PDF)

Non-Anticoagulant Heparins and Inhibition of Cancer

Pathophysiology of haemostasis and thrombosis, 2008, Vol.36 (3-4), p.195-203

2008

Volltextzugriff (PDF)

The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapy

Blood, 2007-09, Vol.110 (6), p.2041-2048

2007

Volltextzugriff (PDF)

Heparanase accelerates wound angiogenesis and wound healing in mouse and rat models

The FASEB journal, 2005-02, Vol.19 (2), p.211-221

2005

Volltextzugriff (PDF)

Re-visiting the structure of heparin

Carbohydrate research, 2015-02, Vol.403, p.60-68

2015

Volltextzugriff (PDF)

Heparin and its derivatives - present and future

Thrombosis and haemostasis, 2009-11, Vol.102 (5), p.801-802

2009

Volltextzugriff (PDF)

The inhibition of the integrin VLA-4 in MV3 melanoma cell binding by non-anticoagulant heparin derivatives

Thrombosis research, 2012-05, Vol.129 (5), p.603-610

2012

Volltextzugriff (PDF)

The tainted heparin story: an update

Thrombosis and haemostasis, 2009-11, Vol.102 (5), p.907-911

2009

Volltextzugriff (PDF)

Structural and Conformational Aspects of the Anticoagulant and Antithrombotic Activity of Heparin and Dermatan Sulfate

Current pharmaceutical design, 2004-04, Vol.10 (9), p.939-949

2004

Volltextzugriff (PDF)

Heparanase, heparin and the coagulation system in cancer progression

Thrombosis research, 2007, Vol.120, p.S112-S120

2007

Volltextzugriff (PDF)

Short Heparin Sequences Spaced by Glycol-Split Uronate Residues Are Antagonists of Fibroblast Growth Factor 2 and Angiogenesis Inhibitors

Biochemistry (Easton), 2002-08, Vol.41 (33), p.10519-10528

2002

Volltextzugriff (PDF)

Antithrombin-binding Octasaccharides and Role of Extensions of the Active Pentasaccharide Sequence in the Specificity and Strength of Interaction

The Journal of biological chemistry, 2008-09, Vol.283 (39), p.26662-26675

2008

Volltextzugriff (PDF)

Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events

Nature biotechnology, 2008-06, Vol.26 (6), p.669-675

2008

Volltextzugriff (PDF)

Profiling glycol-split heparins by high-performance liquid chromatography/mass spectrometry analysis of their heparinase-generated oligosaccharides

Analytical biochemistry, 2013-03, Vol.434 (1), p.112-122

2013

Volltextzugriff (PDF)

Structural features of glycol-split low-molecular-weight heparins and their heparin lyase generated fragments

Analytical and bioanalytical chemistry, 2014-01, Vol.406 (1), p.249-265

2014

Volltextzugriff (PDF)

Heparin dodecasaccharide containing two antithrombin-binding pentasaccharides: structural features and biological properties

The Journal of biological chemistry, 2013-09, Vol.288 (36), p.25895-25907

2013

Volltextzugriff (PDF)

Structural peculiarity and antithrombin binding region profile of mucosal bovine and porcine heparins

Journal of pharmaceutical and biomedical analysis, 2016-01, Vol.118, p.52-63

2016

Volltextzugriff (PDF)

1976-1983, a critical period in the history of heparin: the discovery of the antithrombin binding site

Biochimie, 2003-01, Vol.85 (1-2), p.83-89

2003

Volltextzugriff (PDF)

P-selectin- and heparanase-dependent antimetastatic activity of non-anticoagulant heparins

The FASEB journal, 2007-11, Vol.21 (13), p.3562-3572

2007

Volltextzugriff (PDF)

Antithrombin-binding octasaccharides and role of extensions of the active pentasaccharide sequence in the specificity and strength of interaction. Evidence for very high affinity induced by an unusual glucuronic acid residue

The Journal of biological chemistry, 2008-09, Vol.283 (39), p.26662-26675

2008

Volltextzugriff (PDF)

1 – 25 von 112

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(107)
Mit Volltextzugriff
(97)

Publikationsform

Sprache

Englisch
(112)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate

Heparin-derived heparan sulfate mimics to modulate heparan sulfate-protein interaction in inflammation and cancer

SST0001, a Chemically Modified Heparin, Inhibits Myeloma Growth and Angiogenesis via Disruption of the Heparanase/Syndecan-1 Axis

Modulation of the Heparanase-inhibiting Activity of Heparin through Selective Desulfation, Graded N-Acetylation, and Glycol Splitting

Orthogonal analytical approaches to detect potential contaminants in heparin

Structure and biological interactions of heparin and heparan sulfate

Non-Anticoagulant Heparins and Inhibition of Cancer

The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapy

Heparanase accelerates wound angiogenesis and wound healing in mouse and rat models

Re-visiting the structure of heparin

Heparin and its derivatives - present and future

The inhibition of the integrin VLA-4 in MV3 melanoma cell binding by non-anticoagulant heparin derivatives

The tainted heparin story: an update

Structural and Conformational Aspects of the Anticoagulant and Antithrombotic Activity of Heparin and Dermatan Sulfate

Heparanase, heparin and the coagulation system in cancer progression

Short Heparin Sequences Spaced by Glycol-Split Uronate Residues Are Antagonists of Fibroblast Growth Factor 2 and Angiogenesis Inhibitors

Antithrombin-binding Octasaccharides and Role of Extensions of the Active Pentasaccharide Sequence in the Specificity and Strength of Interaction

Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events

Profiling glycol-split heparins by high-performance liquid chromatography/mass spectrometry analysis of their heparinase-generated oligosaccharides

Structural features of glycol-split low-molecular-weight heparins and their heparin lyase generated fragments

Heparin dodecasaccharide containing two antithrombin-binding pentasaccharides: structural features and biological properties

Structural peculiarity and antithrombin binding region profile of mucosal bovine and porcine heparins

1976-1983, a critical period in the history of heparin: the discovery of the antithrombin binding site

P-selectin- and heparanase-dependent antimetastatic activity of non-anticoagulant heparins

Antithrombin-binding octasaccharides and role of extensions of the active pentasaccharide sequence in the specificity and strength of interaction. Evidence for very high affinity induced by an unusual glucuronic acid residue

Suchergebnisse filtern